| Patent | Date |
|---|
Novel Recombinant Botulinum Neurotoxins With Increased Duration Of Effect
App 20220010294 - FREVERT; Jurgen ; et al. | 2022-01-13 |
Recombinant botulinum neurotoxins with increased duration of effect
Grant 11,155,802 - Frevert , et al. October 26, 2 | 2021-10-26 |
Recombinant clostridial neurotoxins with increased duration of effect
Grant 11,078,472 - Hofmann , et al. August 3, 2 | 2021-08-03 |
Novel Recombinant Botulinum Neurotoxins With Increased Duration Of Effect
App 20210008156 - FREVERT; Jurgen ; et al. | 2021-01-14 |
Novel Recombinant Botulinum Toxin With Increased Duration Of Effect
App 20200354706 - FREVERT; Jurgen ; et al. | 2020-11-12 |
Novel Recombinant Botulinum Neurotoxins With Increased Duration Of Effect
App 20200131494 - FREVERT; Jurgen ; et al. | 2020-04-30 |
Recombinant clostridial neurotoxins with increased duration of effect
Grant 10,603,353 - Frevert , et al. | 2020-03-31 |
Novel Recombinant Botulinum Toxin With Increased Duration Of Effect
App 20200048624 - HOFMANN; Fred ; et al. | 2020-02-13 |
Novel Recombinant Clostridial Neurotoxins With Increased Duration Of Effect
App 20180327730 - Hofmann; Fred ; et al. | 2018-11-15 |
Novel Recombinant Clostridial Neurotoxins With Increased Duration Of Effect
App 20180169182 - Frevert; Jurgen ; et al. | 2018-06-21 |
Recombinant clostridial neurotoxins with increased duration of effect
Grant 9,975,929 - Frevert , et al. May 22, 2 | 2018-05-22 |
Neurotoxins exhibiting shortened biological activity
Grant 9,827,298 - Hofmann , et al. November 28, 2 | 2017-11-28 |
Neurotoxins exhibiting shortened biological activity
Grant 9,809,809 - Schmidt , et al. November 7, 2 | 2017-11-07 |
Neurotoxins Exhibiting Shortened Biological Activity
App 20170072030 - HOFMANN; Fred ; et al. | 2017-03-16 |
Recombinant Clostridial Neurotoxins With Increased Duration Of Effect
App 20170058006 - FREVERT; Jurgen ; et al. | 2017-03-02 |
Neurotoxins exhibiting shortened biological activity
Grant 9,511,114 - Hofmann , et al. December 6, 2 | 2016-12-06 |
Neurotoxins Exhibiting Shortened Biological Activity
App 20160030511 - HOFMANN; Fred ; et al. | 2016-02-04 |
Neurotoxins exhibiting shortened biological activity
Grant 9,193,771 - Hofmann , et al. November 24, 2 | 2015-11-24 |
PEGylated mutated Clostridium botulinum toxin
Grant 9,186,396 - Frevert , et al. November 17, 2 | 2015-11-17 |
Recombinant Clostridial Neurotoxins With Enhanced Membrane Localization
App 20150322118 - GROER; Gerhard ; et al. | 2015-11-12 |
Method For The Manufacturing Of Recombinant Proteins Harbouring An N-terminal Lysine
App 20150232828 - Frevert; Jurgen ; et al. | 2015-08-20 |
PEGylated Mutated Clostridium botulinum Toxin
App 20150166977 - FREVERT; Jurgen ; et al. | 2015-06-18 |
PEGylated mutated clostridium botulinum toxin
Grant 8,912,140 - Frevert , et al. December 16, 2 | 2014-12-16 |
Clostridial neurotoxins with altered persistency
Grant 8,895,713 - Frevert November 25, 2 | 2014-11-25 |
Clostridial Neurotoxins With Altered Persistency
App 20140187755 - FREVERT; Jurgen | 2014-07-03 |
Alteration Of Proteolytic Cleavage Of Botulinum Neurotoxins
App 20140170133 - Frevert; Jurgen | 2014-06-19 |
Clostridial neurotoxins with altered persistency
Grant 8,748,151 - Frevert June 10, 2 | 2014-06-10 |
Neurotoxins Exhibiting Shortened Biological Activity
App 20140045760 - HOFMANN; Fred ; et al. | 2014-02-13 |
Neurotoxins exhibiting shortened biological activity
Grant 8,586,329 - Hofmann , et al. November 19, 2 | 2013-11-19 |
PEGylated Mutated Clostridium botulinum Toxin
App 20130156747 - FREVERT; Jurgen ; et al. | 2013-06-20 |
Therapeutic composition comprising a botulinum neurotoxin
Grant 8,398,998 - Bigalke , et al. March 19, 2 | 2013-03-19 |
PEGylated mutated Clostridium botulinum toxin
Grant 8,298,550 - Frevert , et al. October 30, 2 | 2012-10-30 |
Neurotoxins Exhibiting Shortened Biological Activity
App 20120107362 - Hofmann; Fred ; et al. | 2012-05-03 |
Therapeutic Composition Comprising A Botulinum Neurotoxin
App 20120088732 - Bigalke; Hans ; et al. | 2012-04-12 |
Pegylated Mutated Clostridium Botulinum Toxin
App 20110294747 - Frevert; Jurgen ; et al. | 2011-12-01 |
Therapeutic composition comprising a botulinum neurotoxin
App 20110217287 - Bigalke; Hans ; et al. | 2011-09-08 |
Pegylated mutated clostridium botulinum toxin
Grant 8,003,601 - Frevert , et al. August 23, 2 | 2011-08-23 |
Clostridial Neurotoxins With Altered Persistency
App 20110189158 - Frevert; Jurgen | 2011-08-04 |
Therapeutic composition comprising a botulinum neurotoxin
Grant 7,964,199 - Bigalke , et al. June 21, 2 | 2011-06-21 |
Formulation for a protein pharmaceutical without added human serum albumin (HSA)
Grant 7,829,525 - Frevert November 9, 2 | 2010-11-09 |
Pegylated Mutated Clostridium Botulinum Toxin
App 20090118193 - Frevert; Jurgen ; et al. | 2009-05-07 |
Formulation for a protein pharmaceutical without added human serum albumin (HSA)
App 20070134199 - Frevert; Jurgen | 2007-06-14 |
Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
Grant 6,822,076 - Bigalke , et al. November 23, 2 | 2004-11-23 |
Protein complex serving as a vehicle for orally administerable medicaments
App 20040028703 - Bigalke, Hans ; et al. | 2004-02-12 |
Therapeutic agent for the suppression of snoring noises
Grant 6,573,241 - Bigalke , et al. June 3, 2 | 2003-06-03 |
Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
App 20030059912 - Bigalke, Hans ; et al. | 2003-03-27 |
| 